跳至主要内容
临床试验/NL-OMON49807
NL-OMON49807已完成不适用

The use of pectoral nerve block type II in patients undergoing trans-axillary thoracic outlet decompression. - BLOCKTOS

Catharina-ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with NTOS
  • - Selected for a trans-axillary thoracic outlet decompression (TATOD) by the
  • TOS multidisciplinary workgroup.
  • - Fit for surgery, defined as ASA (American Society of Anesthesiologists)
  • Classification of I, II or III.
  • - 18 years of age or older
  • - Sufficient in speaking and writing the Dutch language
  • - Normal liver and renal function
  • - Informed consent

排除标准

  • - Patients with a history of TOD (Redo-surgery)
  • - Patients with ATOS or VTOS
  • - ASA * 4
  • - Kidney or liver failure with contra-indication for NSAID or paracetamol
  • - Mental retardation
  • - Pregnancy
  • - Patients with chronic strong opioid use (>3 administrations per week or
  • continuous transdermal therapie, longer than the last 3 months)
  • - Allergy to one or more medications used in the study including,
  • ropivacaine, dexamethasone, propofol, sufentanil,
  • succinylcholine,
  • paracetamol, NSAID, morphine, granisetron

研究者

相似试验